Conditions: Breast Neoplasms
Keywords: Metastatic Breast Cancer
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 83
Healthy volunteers: no

Brief summary:
Patients with advanced breast cancer to receive sunitinib (Sutent) once daily until disease progression.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: sunitinib
Intervention descriptions: intervention 1: sunitinib (Sutent), 37.5 mg, daily dosing

Protocol document: